Amgen Inc.(AMGN)Stock Performance & ReturnsNASDAQ
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
AMGN | 237.31 B | 27.26x | 9.50% | 22.95% | $16.10 | 91.47% | 4.90x | 2.27% | $447.03 | $288.00 |
LLY | 1.14 T | 43.09x | 47.70% | 33.53% | $29.79 | 102.29% | 1.62x | 0.51% | $1292.65 | $778.94 |
JNJ | 625.03 B | 39.36x | 5.90% | 16.20% | $6.59 | - | 0.58x | 0.51% | $281.07 | $180.59 |
ABBV | 510.84 B | 81.66x | 10.20% | 9.80% | $3.54 | - | - | 2.39% | $291.40 | $188.25 |
AZN | 261.82 B | 24.26x | 6.40% | 17.02% | $6.96 | 21.97% | 0.64x | 1.95% | $210.52 | $153.41 |
NVO | 131.36 B | 9.62x | 2.10% | 35.35% | $4.09 | 59.82% | 0.63x | 30.13% | $61.11 | $34.15 |
Peer Valuation & Performance Analysis
Peer group analysis for Amgen Inc. (AMGN) compared to its primary competitors (including LLY, JNJ, ABBV) reveals distinct metrics. AMGN trades at a valuation discount relative to its competitors, with a P/E ratio of 27.3x versus the peer average of 40.2x (representing a 32% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, AMGN's revenue growth of 9.5% lags behind the peer average of 12.6%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 22.9% compared to the peer average of 20.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• AMGN ranks #2 in P/E ratio, #3 in revenue growth, and #2 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-20 | $425.58 | $439.05 | $425.11 | $438.94 | 2,141,725 | +3.29% |
| 2026-10-19 | $430.36 | $434.51 | $424.74 | $424.94 | 2,682,800 | -1.75% |
| 2026-10-16 | $437.89 | $438.82 | $431.39 | $432.49 | 2,567,100 | -0.35% |
| 2026-10-15 | $435.83 | $441.76 | $433.42 | $434.03 | 4,625,300 | +1.86% |
| 2026-10-14 | $417.83 | $428.05 | $415.20 | $426.11 | 3,078,800 | +3.21% |
| 2026-10-13 | $420.34 | $420.35 | $411.04 | $412.84 | 2,319,600 | -1.13% |
| 2026-10-12 | $416.12 | $417.76 | $413.44 | $417.57 | 1,720,000 | +0.65% |
| 2026-10-09 | $405.00 | $417.78 | $404.05 | $414.87 | 2,553,000 | +1.82% |
| 2026-10-08 | $409.97 | $411.84 | $400.06 | $407.44 | 2,378,100 | -1.37% |
| 2026-10-07 | $403.06 | $415.79 | $401.85 | $413.08 | 2,236,500 | +2.60% |
| 2026-10-06 | $403.30 | $405.00 | $396.01 | $402.60 | 2,036,500 | -0.09% |
| 2026-10-05 | $399.03 | $403.69 | $397.03 | $402.98 | 3,103,900 | -0.01% |
| 2026-10-02 | $410.16 | $410.16 | $401.96 | $403.04 | 3,510,200 | -1.04% |
| 2026-10-01 | $421.72 | $422.80 | $407.13 | $407.27 | 2,500,500 | -3.38% |
| 2026-09-30 | $424.01 | $426.59 | $420.63 | $421.51 | 3,129,500 | -0.50% |
Explore More Analysis for AMGN
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.